Dube Michael P
Insider CIK 2019493 · NTLA VP, PAO and Interim PFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NTLA Intellia Therapeutics, Inc | S Sale | 2026-10-02 | 2026-10-06 | 1,864 | $12.43 | $23.2K | 65,022 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2026-07-01 | 2026-07-06 | 2,641 | $16.78 | $44.3K | 66,886 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2026-03-01 | 2026-03-03 | 17,250 | — | $0 | 69,527 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2026-01-05 | 2026-01-07 | 2,989 | $9.21 | $27.5K | 52,277 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2025-10-01 | 2025-10-03 | 1,871 | $17.38 | $32.5K | 55,266 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2025-07-02 | 2025-07-03 | 2,503 | $9.95 | $24.9K | 57,137 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2025-03-01 | 2025-03-04 | 14,000 | — | $0 | 59,640 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2025-01-03 | 2025-01-07 | 1,372 | $12.18 | $16.7K | 45,640 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2024-10-02 | 2024-10-04 | 2,012 | $19.01 | $38.2K | 47,012 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2024-07-01 | 2024-07-03 | 17,801 | — | $0 | 49,024 | SEC↗ |